DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
Clinical trial NCT02252653 · COMPLETED
Trial details
- NCT number
- NCT02252653
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 1010
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.